Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
BMC Cancer|September 7, 2019
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypesJasmine A McQuerry, David F Jenkins, Susan E Yost, et al.Cancer Reports (Hoboken, N.J.)|October 1, 2025
Association Between the Volume Transfer Constant (Ktrans) From Dynamic Contrast-Enhanced Perfusion MR and HER2 Status in Breast Cancer Brain MetastasesJonathan R Young, Luke N Ledbetter, Julie A Ressler, et al.Scientific Reports|November 26, 2020
Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancerAngela M Jarrett, David A Hormuth, Vikram Adhikarla, et al.NPJ Precision Oncology|March 30, 2024
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategiesEliza R Bacon, Kena Ihle, Weihua Guo, et al.Journal for Immunotherapy of Cancer|March 24, 2021
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancerColt Egelston, Weihua Guo, Susan Yost, et al.Cold Spring Harbor Molecular Case Studies|May 9, 2023
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinomaDiogo Garcia, Isa Mambetsariev, Jeremy Fricke, et al.Human Pathology|March 27, 2025
Solid basaloid adenoid cystic carcinoma of the breast: A high-grade triple negative breast carcinoma which rarely responds to neoadjuvant chemotherapyKatharine Schulz-Costello, Fang Fan, Daniel Schmolze, et al.Scientific Reports|March 23, 2021
Raman spectroscopy and artificial intelligence to predict the Bayesian probability of breast cancerRagini Kothari, Veronica Jones, Dominique Mena, et al.Oncotarget|July 20, 2019
Differential gene expression and AKT targeting in triple negative breast cancerFeng-Mao Lin, Susan E Yost, Wei Wen, et al.Nature Immunology|July 10, 2019
Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancerLei Wang, Diana L Simons, Xuyang Lu, et al.Pageof 6